Shopping Cart
- Remove All
- Your shopping cart is currently empty
LQVTDSGLYRCVIYHPP (LP17) TFA is a TREM-1 (triggering receptor expressed on myeloid cells) inhibitory peptide that significantly reduces ischemic infarction and neuronal damage, with the ability to penetrate the brain to inhibit TREM-1 [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $60 | In Stock | |
5 mg | $147 | In Stock |
Description | LQVTDSGLYRCVIYHPP (LP17) TFA is a TREM-1 (triggering receptor expressed on myeloid cells) inhibitory peptide that significantly reduces ischemic infarction and neuronal damage, with the ability to penetrate the brain to inhibit TREM-1 [1]. |
In vitro | METHODS: LQVTDSGLYRCVIYHPP (LP17) TFA (1 or 10 μM) was used in microglia to investigate the function of TREM-1 in the microglial OGD model by real-time quantitative PCR. RESULTS: LQVTDSGLYRCVIYHPP (LP17) TFA significantly reduced the mRNA levels of proinflammatory cytokines (NLRP3, IL-1β, IL-18, IL-6, CD16, CD32, and iNOS) and chemokines (MCP-1, CXCL-1, and CXCL-2); microglia incubated with LQVTDSGLYRCVIYHPP (LP17) maximally preserved neuronal viability. [1] |
In vivo | METHODS: LQVTDSGLYRCVIYHPP (LP17) TFA (1 mg/kg, intranasal) was used to confirm the biological function of TREM-1 in ischemic stroke. RESULTS: LQVTDSGLYRCVIYHPP (LP17) TFA induced a significant decrease in TUNEL-positive cells and FJC-positive neurons. [1] |
Molecular Weight | 2075.27 |
Formula | C91H138F3N23O27S |
Smiles | [H]N[C@H](C(N[C@H](C(N[C@H](C(N[C@]([H])(C(N[C@@H](CC(O)=O)C(N[C@H](C(NCC(N[C@H](C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@H](C(N[C@@H](CS)C(N[C@H](C(N[C@]([H])(C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC3=CN=CN3)C(N4CCC[C@H]4C(N5CCC[C@H]5C(O)=O)=O)=O)=O)=O)[C@@H](C)CC)=O)C(C)C)=O)=O)CCCNC(N)=N)=O)=O)CC(C)C)=O)=O)CO)=O)=O)[C@H](O)C)=O)C(C)C)=O)CCC(N)=O)=O)CC(C)C.OC(C(F)(F)F)=O |
Storage | keep away from moisture,store at low temperature | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | H2O: < 1 mg/mL (insoluble) DMSO: 80 mg/mL (38.55 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.